Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.44 |
| ▸ | MAPT | P10636 | 6/20 | 0.44 |
| ▸ | MEN1 | O00255 | 5/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.44 |
| ▸ | NPC1 | O15118 | 4/20 | 0.44 |
| ▸ | RAB9A | P51151 | 4/20 | 0.44 |
| ▸ | GAA | P10253 | 4/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA7 | P43166 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.41 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.41 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29009066 | 0.93 | MEN1 (0.40) | KDM4EMAPTMEN1KMT2ANPC1 | |
| SCHEMBL21712348 | 0.89 | CA12 (0.49) | KDM4EMAPTMEN1KMT2ANPC1 | |
| SCHEMBL28451735 | 0.89 | NPC1 (0.41) | KDM4EMAPTMEN1KMT2ANPC1 | |
| SCHEMBL21712220 | 0.87 | GAA (0.49) | KDM4EMAPTMEN1KMT2ANPC1 | |
| SCHEMBL28445077 | 0.83 | KMT2A (0.37) | KDM4EMAPTMEN1KMT2ANPC1 | |
| SCHEMBL1681173 | 0.77 | MAPT (0.62) | KDM4EMAPTMEN1KMT2ANPC1 | |
| SCHEMBL829753 | 0.77 | CA12 (0.54) | KDM4EMAPTGAASMN1; SMN2CA12 | |
| SCHEMBL2935473 | 0.76 | NQO2 (0.44) | KDM4EMAPTMEN1KMT2AGAA | |
| SCHEMBL28443195 | 0.73 | PKM (0.48) | KDM4EMAPTMEN1KMT2ARAB9A | |
| SCHEMBL168169 | 0.73 | KDM4E (0.41) | KDM4EMAPTMEN1KMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116178680-A | D-A type polymer based on 2,1, 3-benzothiadiazole-5, 6-dicarboxylic acid imide and preparation method and application thereof | 湖南工程学院 | 2023-05-30 | — | — | CN | claimed |
| CN-116178680-A | D-A type polymer based on 2,1, 3-benzothiadiazole-5, 6-dicarboxylic acid imide and preparation method and application thereof | 湖南工程学院 | 2023-05-30 | — | — | CN | disclosed |
| US-9837613-B2 | Conjugated polymers | MERCK PATENT GMBH (DE) | 2017-12-05 | — | — | US | disclosed |
| US-9837613-B2 | Conjugated polymers | MERCK PATENT GMBH (DE) | 2017-12-05 | — | — | US | disclosed |
| US-9153784-B2 | Conjugated polymers | MERCK PATENT GMBH (DE) | 2015-10-06 | — | — | US | disclosed |
| US-9153784-B2 | Conjugated polymers | MERCK PATENT GMBH (DE) | 2015-10-06 | — | — | US | disclosed |
| US-20150270490-A1 | CONJUGATED POLYMERS | MERCK PATENT GMBH (DE) | 2015-09-24 | — | — | US | disclosed |
| US-20150270490-A1 | CONJUGATED POLYMERS | MERCK PATENT GMBH (DE) | 2015-09-24 | — | — | US | disclosed |
| EP-2611851-B1 | CONJUGATED POLYMERS | MERCK PATENT GMBH (DE) | 2014-10-29 | — | — | EP | disclosed |
| US-20130161567-A1 | CONJUGATED POLYMERS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2013-06-27 | — | — | US | disclosed |
| US-20130161567-A1 | CONJUGATED POLYMERS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2013-06-27 | — | — | US | disclosed |
| WO-2012028246-A1 | CONJUGATED POLYMERS | MERCK PATENT GMBH (DE) | 2012-03-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150270490-A1 | CONJUGATED POLYMERS | OCIAD2, PARG, PPOX | KDM4E 1283/4885MAPT 388/4885MEN1 4643/4885 |
| US-20130161567-A1 | CONJUGATED POLYMERS | OCIAD2, PARG, PPOX | KDM4E 1283/4885MAPT 388/4885MEN1 4643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.